Kevin Lee, Bicycle Therapeutics CEO
April 11, 2022 09:24 AM EDTUpdated 10:07 AM
R&D

The one ear­ly biotech bright spot at #AACR22 just turned red

John Carroll

Editor & Founder

Any­one look­ing for fresh ev­i­dence of just how tough this mar­ket has turned need look on­ly to Bi­cy­cle Ther­a­peu­tics this morn­ing.

On Fri­day, the com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

Eu­ro­pean drug reg­u­la­tor re­vers­es opin­ion on Ei­sai and Bio­gen's Alzheimer's drug

Gilead will close Philadel­phia, Seat­tle of­fices as part of job re­duc­tions

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times